IRB Lleida achieve 15 new projects in 2015

These new projects include two in the TV3 Marathon 2014 dedicated to heart disease, 6 Strategic Health Action in 2015 and one of the first European on new technologies and their usefulness in monitoring chronic patients

Lleida, July 27, 2016 The Institute of Biomedical Research Foundation Dr. Lleida Pifarré (IRBLleida) has achieved in its 12 years of life establish itself as a research center of reference in Catalonia and Spain. As shown, during 2015 has reached 15 new research projects in competitive grants with a total awarded for years of 1,834,103.75 euros. These new projects include two in the TV3 Marathon 2014 dedicated to heart disease, 6 Strategic Health Action in 2015 dedicated to type 2 diabetes, bariatric surgery, cancer (two projects) and chronic kidney disease sleep apnea, as well as one of Europe on new technologies and their usefulness in monitoring chronic patients, funded through the prestigious program Horizon2020. Regarding clinical research around IRBLleida in 2015 have started 25 new clinical trials with new drugs and 28 observational studies, which put the total numbers of active studies and clinical trials by 110 by 71 observational studies. Also in 2015 were published 322 scientific papers by researchers from IRBLleida with a total impact factor of 1122.8 points and an average impact factor of 3.5 points. This figure has increased significantly compared to the previous year which was 902 points. An increase indicates the increase in scientific output and quality. In this line of continuous improvement, al'IRBLleida has been granted a new patent applications and has two more underway. Also in 2015 got three awards for research projects: "Identification of lipid biomarkers in cerebrospinal fluid as predictors of the development of Alzheimer's disease in patients with mild cognitive impairment," the lead researcher, Dr. Alba Naudí, "Research on ocular diseases and respiratory diseases," the lead researcher, Dr. Jesus M. Muniesa, "and" Adventitial Vasa vasorum and Subclinical Atheromatosis in HIV Infection, "the lead researcher, Dr. Elvira Fernandez. The director of the IRBLleida, Dra. Elvira Fernandez, who joined the office on month in December 2015 taking over from Dr. Xavier Matias-Guiu, is the consolidation of the research center in Lleida and potential of the territory, "we must work together with other research centers as AGROTECNIO or inspire companies and other stakeholders in the region to look to the future ". And nationally recognized multidisciplinary research. The 30 research groups IRBLleida work in five main areas: stress in biological systems; experimental medicine and therapeutics; • cell phones and molecular models of human diseases; neuroscience and clinical medicine. Of the total group, 17 were distinguished by the Government as a recognized research groups, and of these, 13 belong to the category of established and emerging of the four. Regarding cooperative research and networking IRBLleida has presence in CIBER networks and platforms and participates RETICS state Biobanks and Innovation in Medical Technology. More than 350 researchers are part of the center and they supported his dedication to research with other activities. On the one hand, the expert teaching UdL degrees in medicine, nursing and biomedical mainly; and on the other hand, health care, as in the case of medical specialists from the University Hospital Arnau de Vilanova University Hospital Santa Maria and primary care Health Region Lleida. CREBA The Advanced Biomedical Research Centre (CREBA) located in Torrelameu, is a center dedicated to learning procedures and new surgical techniques, and experimenting with new materials and medical devices. CREB ended 2015 operating rooms equipped with the most advanced training and experimental state. It is designed to provide the best facilities both for research and for training biomedical and has the capacity to carry out up to five simultaneous interventions. New facilities Currently, research groups IRBLleida are located in the building and Biomedicine, a module of 4,000 m2 part by the University of Lleida (UDL), the Catalan Institute of Health (ICS) and the Government of Catalonia . Before the end of 2016, opened the second building Biomedicine II also 4,000 m2 particicipat by the same institutions as well as the Council of Lleida. The IRBLleida is a research institute that brings together all health biomedical research carried out in Lleida, both of the University of Lleida (UDL) and the health system. It includes, therefore, researchers from the Faculty of Medicine of the University of Lleida, the HUAV, the Directorate of Primary Lleida ICS, the territorial services of the Department of Health and the Hospital de Santa Maria ( HUSM). Currently, the management team is working on the new strategic plan (2017-2020) which includes the areas of work of the Institute in the coming years.